InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,590.76
(
0.16%
)
Post# of 252007
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

skitahoe

Send PM Follow Ignore
Followers 242
Posts 12208
Boards Moderated 0
Alias Born 08/14/2003

skitahoe

Re: DewDiligence post# 94746

Friday, 06/04/2010 1:05:15 PM

Friday, June 04, 2010 1:05:15 PM

Post# of 252007
J&J has cut back dramatically on research in the past. IMGN now owns a drug they originally developed for J&J's CNTO unit because of the funding cut. Results for IMGN388 should be reported soon. CNTO does have Opt In rights.

I believe this is a weakness in J&J, not a strength.

Gary
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up